beta-alanine has been researched along with Blood Loss, Postoperative in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we present a first comparison of complications after cardiac rhythm device (CRD) implantations in patients with atrial fibrillation (AF) treated with dabigatran or uninterrupted warfarin." | 9.19 | Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study. ( Bollmann, A; Breithardt, OA; Darma, A; Dinov, B; Doering, M; Hindricks, G; Kosiuk, J; Koutalas, E; Nedios, S; Richter, S; Rolf, S; Sommer, P, 2014) |
| " The association between thromboembolism prophylaxis with dabigatran etexilate or enoxaparin and the perioperative blood loss was investigated." | 7.80 | Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty. ( Doering, M; Egidy, C; Gehrke, T; Kendoff, D; Krettek, C; Mommsen, P; R O Hrs, E, 2014) |
| "We present a successful case of prevention of postoperative hemorrhage in a 70-year-old male on dabigatran, who developed an acute type A aortic dissection and subsequently underwent an emergent ascending aortic replacement." | 7.80 | Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest. ( Ashikhmina, E; Connors, JM; Davidson, M; Jahanyar, J; Mizuguchi, KA; Tomasello, N, 2014) |
| " Based on various everyday situations in clinical routine, the purpose of the present expert recommendations is to provide appropriate perioperative and periinterventional management for patients with atrial fibrillation undergoing long-term treatment with the thrombin inhibitor dabigatran." | 7.78 | Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management. ( Brodmann, M; Domanovits, H; Eber, B; Gottsauner-Wolf, M; Halbmayer, WM; Hiesmayr, JM; Kyrle, PA; Längle, F; Roithinger, FX; Watzke, H; Weltermann, A; Windhager, R; Wolf, C; Zweiker, R, 2012) |
| " Here we present a first comparison of complications after cardiac rhythm device (CRD) implantations in patients with atrial fibrillation (AF) treated with dabigatran or uninterrupted warfarin." | 5.19 | Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study. ( Bollmann, A; Breithardt, OA; Darma, A; Dinov, B; Doering, M; Hindricks, G; Kosiuk, J; Koutalas, E; Nedios, S; Richter, S; Rolf, S; Sommer, P, 2014) |
| "The direct thrombin inhibitor, dabigatran, and the selective factor Xa inhibitors, rivaroxaban and apixaban, are new oral anticoagulants that are approved in many countries for prevention of venous thromboembolism in patients undergoing elective hip or knee arthroplasty." | 4.89 | Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. ( Eriksson, BI; Quinlan, DJ, 2013) |
| "Oral anticoagulant therapy, either with vitamin K antagonists (VKAs) or with novel oral anticoagulants such as dabigatran, rivaroxaban, and apixaban, is the mainstay for thromboprophylaxis in patients with atrial fibrillation (AF)." | 4.89 | Anticoagulation management in nonvalvular atrial fibrillation: current and future directions. ( Kornej, J; Lip, GY; Potpara, T, 2013) |
| " The association between thromboembolism prophylaxis with dabigatran etexilate or enoxaparin and the perioperative blood loss was investigated." | 3.80 | Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty. ( Doering, M; Egidy, C; Gehrke, T; Kendoff, D; Krettek, C; Mommsen, P; R O Hrs, E, 2014) |
| "We present a successful case of prevention of postoperative hemorrhage in a 70-year-old male on dabigatran, who developed an acute type A aortic dissection and subsequently underwent an emergent ascending aortic replacement." | 3.80 | Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest. ( Ashikhmina, E; Connors, JM; Davidson, M; Jahanyar, J; Mizuguchi, KA; Tomasello, N, 2014) |
| " Based on various everyday situations in clinical routine, the purpose of the present expert recommendations is to provide appropriate perioperative and periinterventional management for patients with atrial fibrillation undergoing long-term treatment with the thrombin inhibitor dabigatran." | 3.78 | Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management. ( Brodmann, M; Domanovits, H; Eber, B; Gottsauner-Wolf, M; Halbmayer, WM; Hiesmayr, JM; Kyrle, PA; Längle, F; Roithinger, FX; Watzke, H; Weltermann, A; Windhager, R; Wolf, C; Zweiker, R, 2012) |
| "Dabigatran is an oral direct thrombin inhibitor (DTI) licensed for stroke prevention in atrial fibrillation and likely to be soon approved in Europe for treatment of venous thrombosis." | 2.50 | The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran. ( Alikhan, R; Baglin, T; Benson, G; Green, L; Keeling, D; Marshall, S; Patel, R; Pavord, S; Rayment, R; Rose, P; Tait, C, 2014) |
| "Warfarin has been the primary anticoagulant drug used in the USA for more than 50 years." | 1.38 | Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. ( Firriolo, FJ; Hupp, WS, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 20 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alikhan, R | 1 |
| Rayment, R | 1 |
| Keeling, D | 1 |
| Baglin, T | 1 |
| Benson, G | 1 |
| Green, L | 1 |
| Marshall, S | 1 |
| Patel, R | 1 |
| Pavord, S | 1 |
| Rose, P | 1 |
| Tait, C | 1 |
| Llau, JV | 1 |
| Ferrandis, R | 1 |
| Castillo, J | 1 |
| de Andrés, J | 1 |
| Gomar, C | 1 |
| Gómez-Luque, A | 1 |
| Hidalgo, F | 1 |
| Torres, LM | 1 |
| Davis, C | 1 |
| Robertson, C | 1 |
| Shivakumar, S | 1 |
| Lee, M | 1 |
| Quinlan, DJ | 1 |
| Eriksson, BI | 1 |
| Cohen, AA | 1 |
| Rider, T | 1 |
| Kornej, J | 1 |
| Potpara, T | 1 |
| Lip, GY | 1 |
| Fries, D | 1 |
| Giurea, A | 1 |
| Gütl, M | 1 |
| Halbmayer, WM | 2 |
| Kozek-Langenecker, S | 1 |
| Pachucki, A | 1 |
| Roithinger, F | 1 |
| Steinlechner, B | 1 |
| Thaler, H | 1 |
| Weltermann, A | 2 |
| Bloch, BV | 1 |
| Patel, V | 1 |
| Best, AJ | 1 |
| Gombár, C | 1 |
| Horvath, G | 1 |
| Gálity, H | 1 |
| Sisák, K | 1 |
| Tóth, K | 1 |
| John, A | 1 |
| Michel, MS | 1 |
| McCormick, NJ | 1 |
| Moore, UJ | 1 |
| Meechan, JG | 1 |
| Norouzi, M | 1 |
| Kosiuk, J | 1 |
| Koutalas, E | 1 |
| Doering, M | 2 |
| Nedios, S | 1 |
| Sommer, P | 1 |
| Rolf, S | 1 |
| Darma, A | 1 |
| Breithardt, OA | 1 |
| Dinov, B | 1 |
| Hindricks, G | 1 |
| Richter, S | 1 |
| Bollmann, A | 1 |
| Mommsen, P | 1 |
| R O Hrs, E | 1 |
| Egidy, C | 1 |
| Gehrke, T | 1 |
| Krettek, C | 1 |
| Kendoff, D | 1 |
| Ashikhmina, E | 1 |
| Tomasello, N | 1 |
| Connors, JM | 1 |
| Jahanyar, J | 1 |
| Davidson, M | 1 |
| Mizuguchi, KA | 1 |
| Scott, A | 1 |
| Gibson, J | 1 |
| Crighton, A | 1 |
| Warkentin, TE | 1 |
| Margetts, P | 1 |
| Connolly, SJ | 1 |
| Lamy, A | 1 |
| Ricci, C | 1 |
| Eikelboom, JW | 1 |
| Brodmann, M | 1 |
| Domanovits, H | 1 |
| Eber, B | 1 |
| Gottsauner-Wolf, M | 1 |
| Hiesmayr, JM | 1 |
| Kyrle, PA | 1 |
| Längle, F | 1 |
| Roithinger, FX | 1 |
| Watzke, H | 1 |
| Windhager, R | 1 |
| Wolf, C | 1 |
| Zweiker, R | 1 |
| Firriolo, FJ | 1 |
| Hupp, WS | 1 |
| Lillo-Le Louët, A | 1 |
| Wolf, M | 1 |
| Soufir, L | 1 |
| Galbois, A | 1 |
| Dumenil, AS | 1 |
| Offenstadt, G | 1 |
| Samama, MM | 1 |
| Spannagl, M | 1 |
| Bauersachs, R | 1 |
| Debus, ES | 1 |
| Gawaz, M | 1 |
| Gerlach, H | 1 |
| Haas, S | 1 |
| Hach-Wunderle, V | 1 |
| Lindhoff-Last, E | 1 |
| Riess, H | 1 |
| Schellong, S | 1 |
| Schinzel, H | 1 |
| Bode, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Observational Study of the Direct Oral Anticoagulants Periprocedural Management[NCT03182218] | 1,100 participants (Actual) | Observational | 2015-02-28 | Completed | |||
| Prospective Study of the Assessment of the Dental Protocol for Tooth Extraction in Patients With Atrial Fibrillation in Continuous Use of New Oral Anticoagulants: A Pilot Study[NCT03181386] | Phase 3 | 60 participants (Actual) | Interventional | 2017-05-03 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for beta-alanine and Blood Loss, Postoperative
| Article | Year |
|---|---|
The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Disease Management | 2014 |
[Recommendations on use of direct oral anticoagulants in the perioperative period].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran | 2012 |
Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
Topics: Administration, Oral; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Hu | 2013 |
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Dabig | 2013 |
NOACs for thromboprophylaxis in medical patients.
Topics: Administration, Oral; Aged; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administr | 2013 |
Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ab | 2013 |
2 trials available for beta-alanine and Blood Loss, Postoperative
| Article | Year |
|---|---|
Comparison of minor bleeding complications using dabigatran or enoxaparin after cemented total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanin | 2014 |
Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Case-Cont | 2014 |
12 other studies available for beta-alanine and Blood Loss, Postoperative
| Article | Year |
|---|---|
Management of dabigatran-induced bleeding: expert statement.
Topics: Administration, Oral; Antithrombins; Austria; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; | 2013 |
Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replace | 2014 |
[Rivaroxaban, dabigatran and apixaban: new anticoagulants in operative urology].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Dabigatran | 2014 |
Haemostasis. Part 2: Medications that affect haemostasis.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Drug Interactions; Fibrinol | 2014 |
Effects of thromboembolism prophylaxis with dabigatran on perioperative blood loss and wound secretion in primary hip arthroplasty.
Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Body Fluids; Dabi | 2014 |
Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest.
Topics: Aged; Antithrombins; Aortic Aneurysm, Thoracic; Aortic Dissection; Benzimidazoles; beta-Alanine; Dab | 2014 |
The management of dental patients taking new generation oral anticoagulants.
Topics: Anesthetics, Local; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dental | 2014 |
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
Topics: Aged; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Factor VIIa; Humans; Male; | 2012 |
Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
Topics: Atrial Fibrillation; Austria; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Periop | 2012 |
Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antithrombins; Benzim | 2012 |
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Topics: Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement; Atrial Fibrillation; Benzimidazol | 2012 |
[Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Tests; Dabigatran; Humans; Monitoring | 2012 |